HBAN vs ITRM · P/E 13, rev $1.56B vs rev $390.0K
Huntington Bancshares Incorporated (HBAN) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the HBAN and ITRM stock pages for the full models.
Not investment advice.